Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease

Journal of Neuroscience Methods

Volumn 179, Issue 2, 2009, Pages 219-223

  Jiang, Wei ^a,b   Büchele, Fabian ^a   Papazoglou, Anna ^a   Döbrössy, Máté ^a   Nikkhah, Guido ^a  

^a Neurocenter   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Anaesthesia; Excitotoxicity; Huntington's disease model; Isoflurane; Ketamine; Neurodegeneration

Indexed keywords

APOMORPHINE; ISOFLURANE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYGEN; QUINOLINIC ACID; XYLAZINE;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HISTOLOGY; HUNTINGTON CHOREA; MOTOR ACTIVITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION;

ANESTHETICS, INHALATION; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BRAIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUNTINGTON DISEASE; ISOFLURANE; KETAMINE; NEURONS; NEUROTOXINS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 63049113624     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2009.01.033     Document Type: Article

References (36)

1. Bazzett T., Geiger A., Coppola B., and Albin R. The neuronal NOS inhibitor L-MIN, but not 7-NINA, reduces neurotoxic effects of chronic intrastriatal administration of quinolinic acid. Brain Res 775 (1997) 229-232
2. Bazzett T., Legnard E., Bauter M.R., and Albin R.L. Time-course analysis and comparison of acute and chronic intrastriatal quinolinic acid administration on forelimb reaching deficits in the rat. Exp Neuro 158 (1999) 126-134
3. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., and Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321 (1986) 168-171
4. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., and Martin J.B. Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8 (1988) 3901-3908
5. Brady R.J., and Swann J.W. Ketamine selectively suppresses synchronized afterdischarges in immature hippocampus. Neurosci Lett 69 (1986) 143-149
6. Choi D.W. Excitotoxic cell death. J Neurobiol 23 (1992) 1261-1276
7. Döbrössy M.D., and Dunnett S.B. Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease. Neuroscience 132 (2005) 543-552
8. Döbrössy M.D., and Dunnett S.B. The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease. Behav Brain Res 179 (2007) 326-330
9. Figueredo-Cardenas G., Chen Q., and Reiner A. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp Neuro 146 (1997) 444-457
10. Figueredo-Cardenas G., Harris C.L., Anderson K.D., and Reiner A. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp Neuro 149 (1998) 356-372
11. Franks N.P. Molecular targets underlying general anaesthesia. Br J Pharmacol 147 Suppl 1 (2006) S72-S81
12. Fricker R.A., Annett L.E., Torres E.M., and Dunnett S.B. The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation. Brain Res Bull 41 (1996) 409-416
13. Graybiel A.M., Liu F.C., and Dunnett S.B. Intrastriatal grafts derived from fetal striatal primordial. I. Phenotypy and modular organization. J Neurosci 9 (1989) 3250-3271
14. Gross M.E. Tranquilizers, α2-adrenergic agonists and related agents. In: Adams H.R. (Ed). Veterinary pharmacology and therapeutics (2001), Iowa State University Press, Ames 299-342
15. Handley O.J., Naji J.J., Dunnett S.B., and Rosser A.E. Pharmaceutical, cellular and genetic therapies for Huntington's disease. Clin Sci (Lond) 110 (2006) 73-88
16. Harada H., Kelly P.J., Cole D.J., Drummond J.C., and Patel P.M. Isoflurane reduces N-methyl-d-aspartate toxicity in vivo in the rat cerebral cortex. Anesth Analg 89 (1999) 1442-1447
17. Henschke G., Wolf G., and Keilhoff G. Ketamine, but not glycine modulates quinolinate-induced neurodegeneration. Pol J Pharmacol 45 (1993) 339-347
18. Kudo M., Aono M., Lee Y., Massey G., Pearlstein R.D., and Warner D.S. Effects of volatile anesthetics on N-methyl-d-aspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiology 95 (2001) 756-765
19. Langley K.C., Bergson C., Greengard P., and Ouimet C.C. Co-localization of the D1 dopamine receptor in a subset of DARPP-32 containing neurones in rat caudate-putamen. Neuroscience 78 (1997) 977-983
20. Lee S.T., Park J.E., Lee K., Kanga L., Chua K., Kim S.U., et al. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease. J Neurosci Meth 152 (2006) 250-254
21. Lei H., Grinberg O., Nwaigwe C.I., Hou H.G., Williams H., Swartz H.M., et al. The effect of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res 913 (2001) 174-179
22. Lodge D., and Johnston G.A. Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in vitro. Neurosci Lett 56 (1985) 371-375
23. Olney J., Price M., Salles K.S., Labruyere J., and Frierdich G. MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Eur J Pharmacol 141 (1987) 357-361
24. Ouimet C.C., and Greengard P. Distribution of DARPP-32 in the basal ganglia: an electron microscopy study. J Neurocytol 19 (1990) 39-52
25. Pearce R.A., Stringer J.L., and Lothman E.W. Effect of volatile anesthetics on synaptic transmission in the rat hippocampus. Anesthesiology 71 (1989) 591-598
26. Ramaswamy S., McBride J.L., and Kordower J.H. Animal models of Huntington's disease. ILAR J 48 (2007) 356-373
27. Richardson C.A., and Flecknell P.A. Anaesthesia and post-operative analgesia following experimental surgery in laboratory rodents: are we making progress?. Altern Lab Anim 33 (2005) 119-127
28. Roberts R.C., and DiFiglia M. Short- and long-term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: a light and electron microscopic study. Synapse 3 (1989) 363-371
29. Ryu J.K., Choi H.B., and McLarnon J.G. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease. Neuroscience 141 (2006) 1835-1848
30. Shear D.A., Dong J., Gundy C.D., Haik-Creguer K.L., and Dunbar G.L. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog Neuropsychopharm Biol Psych 22 (1998) 1217-1240
31. Shear D.A., Dong J., Haik-Creguer K.L., Bazzett T.J., Albin R.L., and Dunbar G.L. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Exp Neuro 150 (1998) 305-311
32. Solt K., and Foreman S.A. Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol 20 (2007) 300-306
33. Song J., Lee S.T., Kang W., Park J.E., Chu K., Lee S.E., et al. Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett 423 (2007) 58-61
34. Visnyei K., Tatsukawa K.J., Erickson R.I., Simonian S., Oknaian N., Carmichael S.T., et al. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neuro 197 (2006) 465-474
35. Wright M. Pharmacological effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc 180 (1982) 1462-1471
36. Zheng S., and Zuo Z. Isoflurane preconditioning decreases glutamate receptor overactivation-induced Purkinje neuronal injury in rat cerebellar slices. Brain Res 1054 (2005) 143-151